Five Questions

  • Quashing myths about PTSD

    Shaili Jain, a Stanford psychiatrist, discusses the explosion of knowledge about post-traumatic stress disorder and the condition’s widespread impact. PTSD is the subject of her new book, The Unspeakable Mind.

  • Finding strategies for professional wellness

    Rachel Schwartz discusses a study in which Stanford Presence 5 researchers interviewed people in non-medical professions to see how they and their organizations foster professional wellness on the job.

  • Nicotine arms race

    In this Q&A, Robert Jackler, a professor who has studied the rapid rise of e-cigarettes among youth, discussed the impact of Juul, a high-nicotine vaping device.

  • Cutting back on meat-derived protein

    Nutrition expert Christopher Gardner discusses the protein-consuming habits of America, the drawbacks and ways to eat better.

  • Progress in peanut-allergy immunotherapy

    As immunotherapy for peanut allergy advances, a Stanford allergy expert discusses what that means for parents, providers and the future of allergy treatments.

  • The basics of acute flaccid myelitis

    Small clusters of cases of infectious paralysis are occurring in young children across North America. A Stanford pediatric neurologist is working to understand the disease.

  • What to know about concussions

    Angela Lumba-Brown, MD, co-director of the Stanford Concussion and Brain Performance Center, is the lead author of the newly published CDC Guidelines on the Management of Mild Traumatic Brain Injury in Children. In a recent interview, she explained what families should know about concussions.

  • Innovations in kids’ MRI scans

    Stanford pediatric radiologist Shreyas Vasanawala is tailoring MRI equipment to children. His work allows young patients to receive faster MRI exams that require less anesthesia.

  • Zulman on engaging high-need patients

    Patient engagement requires creativity, trust building and flexibility from health care providers, especially when treating high-need patients, a new Stanford study says.

  • New therapy for drug-resistant epilepsy

    The FDA has approved the use of an implanted device that releases periodic electrical discharges in the brain to counteract seizures in people with epilepsy. In an interview, neurologist Robert Fisher described the technology and Stanford’s role in testing the device.

COVID-19 Updates

Stanford Medicine is closely monitoring the outbreak of novel coronavirus (COVID-19). A dedicated page provides the latest information and developments related to the pandemic.

Leading In Precision Health

Stanford Medicine is leading the biomedical revolution in precision health, defining and developing the next generation of care that is proactive, predictive and precise.